SELLAS Life Sciences Grou...
(SLS)
undefined
undefined%
At close: undefined
0.86
-1.64%
After-hours Dec 13, 2024, 07:59 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 |
| Net Income | -37.34M | -41.30M | -20.70M | -16.76M | -19.29M | -27.67M | -23.75M | -11.10M | -38.96M | -36.61M | -76.68M | -34.97M | -11.48M | -11.99M | -18.39M | -14.37M | -10.99M | -2.40M |
| Depreciation & Amortization | - | 457.00K | 5.68M | 282.00K | 1.70M | 3.76M | - | 142.00K | 355.00K | 889.00K | 452.00K | 49.00K | 163.00K | 172.00K | 162.00K | 131.00K | 36.00K | - |
| Stock-Based Compensation | 1.39M | 1.73M | 1.01M | 578.00K | 573.00K | 395.00K | 3.17M | 2.26M | 1.93M | 5.39M | 2.53M | 1.39M | 3.00M | 4.37M | 4.20M | - | - | - |
| Other Working Capital | 1.04M | 4.43M | -5.10M | 6.43M | -1.12M | -2.07M | -2.30M | -24.16M | 20.16M | 3.00M | 5.89M | -535.00K | 2.06M | 213.00K | 54.00K | -344.00K | 753.00K | -181.00K |
| Other Non-Cash Items | 1.20M | 10.13M | -4.16M | -87.00K | 586.00K | 4.42M | 3.53M | -11.55M | -31.73M | -170.00K | 41.23M | 13.51M | -21.29M | -3.12M | 1.97M | 4.82M | 4.23M | 474.00K |
| Deferred Income Tax | - | -457.00K | -239.00K | -23.00K | -95.00K | -1.32M | - | 243.00K | 365.00K | -16.36M | 1.05M | -1.05M | 12.39M | - | 4.00K | - | - | - |
| Change in Working Capital | 3.35M | 5.64M | -7.62M | 5.59M | -1.11M | -10.01M | 6.07M | -24.91M | 19.87M | 3.99M | 2.51M | 106.00K | 2.56M | 312.00K | 285.00K | -5.00K | 674.00K | -181.00K |
| Operating Cash Flow | -31.41M | -23.81M | -26.02M | -10.42M | -17.64M | -30.42M | -10.99M | -44.91M | -48.16M | -42.87M | -28.91M | -20.96M | -14.67M | -10.26M | -11.77M | -9.43M | -6.05M | -2.11M |
| Capital Expenditures | -5.50M | -4.50M | - | - | - | - | - | -6.00K | -153.00K | -5.53M | -15.85M | - | -53.00K | -106.00K | -83.00K | -166.00K | -229.00K | - |
| Acquisitions | - | - | - | - | - | - | 1.81M | - | - | - | - | -87.00K | 168.00K | 106.00K | - | - | - | - |
| Purchase of Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | -5.99M | - | -19.79M | -11.76M | - |
| Sales Maturities Of Investments | - | - | - | - | - | - | - | - | - | - | 3.91M | - | - | 5.99M | - | 29.53M | 1.98M | - |
| Other Investing Acitivies | -5.50M | -4.50M | - | - | - | - | - | -1.05M | 10.55M | -5.53M | -99.00K | -87.00K | -101.00K | -106.00K | - | 21.00K | -16.00K | - |
| Investing Cash Flow | -5.50M | -4.50M | - | - | - | - | 1.81M | -1.06M | 10.39M | -5.53M | -12.04M | -87.00K | 14.00K | -106.00K | -83.00K | 9.60M | -10.03M | - |
| Debt Repayment | - | - | - | - | - | -7.60M | -473.00K | 16.50M | -3.91M | -1.77M | 9.87M | 500.00K | 416.00K | -70.00K | -34.00K | -22.00K | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.85M | - | - | - | - |
| Dividend Paid | - | - | - | - | - | -487.00K | -675.00K | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 90.00K | 85.00K | 3.07M | 8.84M | 3.60M | 9.65M | - | - | 31.00K | 15.06M | 8.36M | 5.45M | 150.00K | 254.00K | - | 26.00K | 2.00M | 2.11M |
| Financial Cash Flow | 22.32M | 24.08M | 12.07M | 38.44M | 19.57M | 23.12M | 5.53M | 34.32M | 43.84M | 24.26M | 55.92M | 42.42M | 19.20M | 11.57M | 7.68M | 7.92M | 17.83M | 2.11M |
| Net Cash Flow | -14.60M | -4.23M | -13.95M | 28.02M | 1.93M | -7.30M | -3.64M | -11.65M | 6.08M | -24.14M | 14.98M | 21.37M | 4.54M | 1.21M | -4.17M | 8.09M | 1.76M | - |
| Free Cash Flow | -36.91M | -28.31M | -26.02M | -10.42M | -17.64M | -30.42M | -10.99M | -44.92M | -48.31M | -48.40M | -44.76M | -20.96M | -14.72M | -10.36M | -11.85M | -9.60M | -6.28M | -2.11M |